In prostate cancer, in vitro and in vivo xenograft experiments using DU145 SOX2-overexpressing cells in NOD/SCID mice revealed that SOX2 caused an increase in apoptotic resistance by decreasing store-operated Ca2+ entry via repressing ORAI1 expression (Figure 2) [58]. The gene discussed is SOX2; the disease is prostate cancer.